High expression of PD-L1 on both antigen-presenting cells (APCs) and tumor cells not only triggers the PD-1/PD-L1 axis of T cells but also activates PD-L1/CD80 interactions on dendritic cells (DCs), leading to immunosuppression [5]. This evidence concerns the gene CD274 and neoplasm.